Sign in
Taking people in United StatesNo phase

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens

Key facts

Who runs it
SightGlass Vision, Inc.
Where
Athens, Beaumont, Bellaire, Boston, Chicago, Granville, Longwood, Marietta, Oakland, Pittsburg, Raytown, San Diego, San Francisco, and Santa Ana, United StatesSee the 14 sites
Trial code
Status
Recruiting
People taking part
150 people, planned
Started
18 Sept 2023
Expected to end
31 Mar 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Single vision, impact-resistant spectacle lenses; Test Arm
  • Single vision, impact-resistant spectacle lenses; Control Arm
Record updated
29 December 2025

Who can take part

Age
6 years to 8 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (18)Hide the full registry criteria

Who can take part

  • Children 6 - 8 years of age (inclusive) at time of informed consent/assent
  • Spherical equivalent refractive error between -0.75 and -4.50 D inclusive (by manifest refraction) in each eye
  • Astigmatism if present, less than or equal to -1.25 DC (by manifest refraction) in each eye
  • Best corrected visual acuity by manifest refraction of +0.10 logMAR (20/25 Snellen equivalent) or better in each eye
  • The difference in spherical equivalent power between the two eyes (anisometropia based on manifest refraction) must be less than or equal to 1.50 D
  • Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day)
  • Ability to comply with study procedures, including high and low contrast visual acuity, axial length, and cycloplegic autorefraction measurements taken for both eyes at the baseline visit
  • Willingness to participate in the trial for 24 months without contact lens wear
  • The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of the form

Who cannot take part

  • Subject has previously or currently wears contact lenses (greater than 1-month usage)
  • Current or prior use of bifocals, progressive addition spectacle lenses
  • Current or prior use of any myopia control treatment (e.g., atropine, multifocal contact lenses, orthokeratology)
  • Any ocular or systemic conditions that could influence refractive development or status [e.g., keratoconus, congenital glaucoma, ocular trauma, diabetes, Marfan syndrome or other connective tissue disorder, Down's syndrome, family history of poor night vision (to prevent against enrolling subjects with congenital stationary night blindness)]
  • Known allergy to proparacaine, tetracaine, or tropicamide
  • Amblyopia in either eye
  • Strabismus by cover test at far (4 m) or near (40 cm) wearing distance correction
  • Participation in any investigational clinical study within 30 days of the Baseline visit
  • Subject's sibling or other household member is already enrolled in this trial

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Myopia

This trial is currently available in United States.

  • Athens Eye CareAthens, United StatesContact: Jen BriteTaking people
  • Texas State Optical - DowlenBeaumont, United StatesContact: Bobbie HamptonTaking people
  • Bellaire Family Eye CareBellaire, United StatesContact: Ashley Tucker, ODTaking people
  • New England College of OptometryBoston, United StatesContact: Lilly CheamTaking people
  • Ilinois College of OptometryChicago, United StatesContact: Jessica MartinezTaking people
  • Procare Vision Centers, Inc.Granville, United StatesContact: Katherine Bickle, ODTaking people
  • Omega Vision CenterLongwood, United StatesContact: Renee WarrenTaking people
  • Marietta Eye ClinicMarietta, United StatesContact: Doreatha KennerlyTaking people
  • Elsa Pao, ODOakland, United StatesContact: Vanessa ChenTaking people
  • Kannarr Eye CarePittsburg, United StatesContact: Megan Compton, RNTaking people
  • Advanced Eyecare, PCRaytown, United StatesContact: Tamara UriasTaking people
  • Scripps Poway EyecareSan Diego, United StatesContact: Leslie Shan, ODTaking people
  • Pacific Rims OptometrySan Francisco, United StatesContact: Aileen GuzmanTaking people
  • Paje OptometricSanta Ana, United StatesContact: Daisy MagdalenoTaking people

About the trial

What the trial wants to find out

This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will be used to predict the 3-year treatment efficacy.

Read full original descriptionShow less

This is a randomized, controlled (1:1), multisite, subject- and observer-masked, 2-arm parallel group study.

The 2 groups in the trial

  • Test Arm 1Treatment being tested

    Single vision, impact-resistant spectacle lenses

    Treatment: Single vision, impact-resistant spectacle lenses; Test Arm

  • Test Arm 2Other group

    Single vision, impact-resistant spectacle lenses

    Treatment: Single vision, impact-resistant spectacle lenses; Control Arm

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT06034327, who can take part
Record updated
29 December 2025